Personalised cancer medicine Future crafting in the genomic era

What does it mean to personalise cancer medicine? Personalised cancer medicine explores this question by foregrounding the experiences of patients, carers and practitioners in the UK. Drawing on an ethnographic study of cancer research and care, we trace patients’, carers’ and practitioners’ efforts...

Full description

Bibliographic Details
Main Author: Kerr, Anne
Other Authors: Key Chekar, Choon, Ross, Emily, Swallow, Julia
Format: eBook
Language:English
Published: Manchester Manchester University Press 2021
Subjects:
Online Access:
Collection: OAPEN - Collection details see MPG.ReNa
LEADER 03118nma a2200445 u 4500
001 EB002062119
003 EBX01000000000000001203230
005 00000000000000.0
007 cr|||||||||||||||||||||
008 220825 ||| eng
100 1 |a Kerr, Anne 
245 0 0 |a Personalised cancer medicine  |h Elektronische Ressource  |b Future crafting in the genomic era 
260 |a Manchester  |b Manchester University Press  |c 2021 
300 |a 288 p. 
653 |a patients 
653 |a Social and cultural anthropology 
653 |a genomics 
653 |a participation 
653 |a cancer 
653 |a personalised medicine 
653 |a care 
653 |a Medical genetics 
653 |a Medical sociology 
653 |a precision medicine 
653 |a futures 
653 |a technoscience 
653 |a oncology 
700 1 |a Key Chekar, Choon 
700 1 |a Ross, Emily 
700 1 |a Swallow, Julia 
041 0 7 |a eng  |2 ISO 639-2 
989 |b OAPEN  |a OAPEN 
500 |a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/ 
856 4 2 |u https://library.oapen.org/handle/20.500.12657/46714  |z OAPEN Library: description of the publication 
856 4 0 |u https://library.oapen.org/bitstream/id/165929e5-2dfc-4a88-b738-6d73019049e7/9781526141019_fullhl.pdf  |x Verlag  |3 Volltext 
082 0 |a 700 
082 0 |a 301 
082 0 |a 610 
082 0 |a 300 
520 |a What does it mean to personalise cancer medicine? Personalised cancer medicine explores this question by foregrounding the experiences of patients, carers and practitioners in the UK. Drawing on an ethnographic study of cancer research and care, we trace patients’, carers’ and practitioners’ efforts to access and interpret novel genomic tests, information and treatments as they craft personal and collective futures. Exploring a series of case studies of diagnostic tests, research and experimental therapies, the book charts the different kinds of care and work involved in efforts to personalise cancer medicine and the ways in which benefits and opportunities are unevenly realised and distributed. Investigating these experiences against a backdrop of policy and professional accounts of the ‘big’ future of personalised healthcare, the authors show how hopes invested and care realised via personalised cancer medicine are multifaceted, contingent and, at times, frustrated in the everyday complexities of living and working with cancer. Tracing the difficult and painstaking work involved in making sense of novel data, results and predictions, we show the different futures crafted across policy, practice and personal accounts. This is the only book to investigate in depth how personalised cancer medicine is reshaping the futures of cancer patients, carers and professionals in uneven and partial ways. Applying a feminist lens that focuses on work and care, inclusions and exclusions, we explore the new kinds of expertise, relationships and collectives involved making personalised cancer medicine work in practice and the inconsistent ways their work is recognised and valued in the process.